A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Brompheniramine
Procaterol
The risk or severity of hypokalemia can be increased when Budesonide is combined with Procaterol.
Brompheniramine
Ephedra sinica root
The risk or severity of hypokalemia can be increased when Budesonide is combined with Ephedra sinica root.
Brompheniramine
Pirbuterol
The risk or severity of hypokalemia can be increased when Budesonide is combined with Pirbuterol.
Brompheniramine
Fenoterol
The risk or severity of hypokalemia can be increased when Budesonide is combined with Fenoterol.
Brompheniramine
Arformoterol
The risk or severity of hypokalemia can be increased when Budesonide is combined with Arformoterol.
Brompheniramine
Arbutamine
The risk or severity of hypokalemia can be increased when Budesonide is combined with Arbutamine.
Brompheniramine
Isoprenaline
The risk or severity of hypokalemia can be increased when Budesonide is combined with Isoprenaline.
Brompheniramine
Bitolterol
The risk or severity of hypokalemia can be increased when Budesonide is combined with Bitolterol.
Brompheniramine
Ritodrine
The risk or severity of hypokalemia can be increased when Budesonide is combined with Ritodrine.
Brompheniramine
Dobutamine
The risk or severity of hypokalemia can be increased when Budesonide is combined with Dobutamine.
Brompheniramine
Deferasirox
The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Budesonide is combined with Deferasirox.
Brompheniramine
Corticorelin ovine triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Budesonide.
Brompheniramine
Ceritinib
The risk or severity of hyperglycemia can be increased when Budesonide is combined with Ceritinib.
Brompheniramine
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be increased when combined with Budesonide.
Brompheniramine
Aripiprazole
The metabolism of Aripiprazole can be increased when combined with Budesonide.
Brompheniramine
Pralsetinib
Pralsetinib may decrease the excretion rate of Budesonide which could result in a higher serum level.
Brompheniramine
Letermovir
Letermovir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Brompheniramine
Lenvatinib
Lenvatinib may decrease the excretion rate of Budesonide which could result in a higher serum level.
Brompheniramine
Simeprevir
Simeprevir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Brompheniramine
Fusidic acid
Fusidic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3